ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
雍和植发(临时代码)
成交量:
- -
成交额:
- -
市值:
- -
市盈率:
- -
高:
- -
开:
- -
低:
- -
收:
- -
52周最高:
- -
52周最低:
- -
股本:
- -
香港流通股本:
- -
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
市销率:
- -
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
交银国际:重申康方生物(09926)“买入”评级 目标价63港元
智通财经
·
2021/04/13
康方生物-B(09926-HK)跌6.09%
财华社
·
2021/04/12
康方生物-B:双抗龙头再创佳绩,biopharma进阶之路正式开启
格隆汇APP
·
2021/04/12
格隆汇港股通5日资金流入流出排行榜 | 4月9日
格隆汇
·
2021/04/10
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/90010"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"90010","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90010\",,,,,undefined,":{"symbol":"90010","market":"HK","secType":"STK","nameCN":"雍和植发(临时代码)","latestPrice":0,"timestamp":1771833600000,"preClose":0,"halted":8,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0,"latestTime":"02-23 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"symbolChange":{"newSymbol":"09926","executeDate":"2020-04-14"},"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1771810200000,1771819200000],[1771822800000,1771833600000]],"volumeRatio":0,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90010\",,,,,undefined,":{"symbol":"90010","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90010\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2020-04-14","symbol":"90010","oldSymbol":"90010","newSymbol":"09926","exchange":"SEHK","type":"symbolChange","dateTimestamp":1586793600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90010\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90010\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"90010\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2127509492","title":"交银国际:重申康方生物(09926)“买入”评级 目标价63港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2127509492","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2127509492?lang=zh_cn&edition=fundamental","pubTime":"2021-04-13 11:01","pubTimestamp":1618282909,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,交银国际发布研究报告,重申康方生物“买入”评级,目标价63港元。报告中称,公司去年收入为1.24亿元人民币,主要为政府补贴和利息收入。净亏损13.2 亿元人民币,主要因为高于预期的研发支出,以及可转换可赎回优先股的公允价值损失。管理层预计,2021年下半年将就宫颈癌适应症提交新药注册。另外,旗下治疗三线经典霍奇金淋巴瘤适应症的AK105已提交新药注册,预计今年上市。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/447500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03329","09926","90010"],"gpt_icon":0},{"id":"2126530057","title":"康方生物-B(09926-HK)跌6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2126530057","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2126530057?lang=zh_cn&edition=fundamental","pubTime":"2021-04-12 15:13","pubTimestamp":1618211580,"startTime":"0","endTime":"0","summary":"康方生物-B(09926-HK)截至15:09下跌6.09%,现报50.1港元,跌3.25港元。成交198万股,涉资1.01亿元。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202104121880562382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["90010","09926"],"gpt_icon":0},{"id":"2126239062","title":"康方生物-B:双抗龙头再创佳绩,biopharma进阶之路正式开启","url":"https://stock-news.laohu8.com/highlight/detail?id=2126239062","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2126239062?lang=zh_cn&edition=fundamental","pubTime":"2021-04-12 09:30","pubTimestamp":1618191054,"startTime":"0","endTime":"0","summary":"PD-1单药Balstilimab的ORR为11.9%,Pembrolizumab的ORR为14.3%。02 AK112:联合抗血管机制,First-in-Class品种AK112则是全球目前唯一进入临床开发阶段的基于PD-1/VEGF的双抗产品,也是康方继AK104之后第二款全球首创并进入临床开发阶段的双抗药物。未来,康方生物的AK112上市之后,或将成为另一个极具竞争力的重磅双抗产品。康方生物与中国生物制药旗下正大天晴共同开发及商业化派安普利单抗,派安普利是中国生物制药唯一可用于开发基于PD-1抗体的单一疗法或联合疗法的新药。","market":"us","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://k.sina.cn/article_5115326071_130e5ae7700101bk55.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://k.sina.cn/article_5115326071_130e5ae7700101bk55.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["09926","90010"],"gpt_icon":0},{"id":"2126086036","title":"格隆汇港股通5日资金流入流出排行榜 | 4月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2126086036","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2126086036?lang=zh_cn&edition=fundamental","pubTime":"2021-04-10 05:10","pubTimestamp":1618002602,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示,心动公司,微盟集团,山东墨龙,康方生物-B,海吉亚医疗港股通五日资金显著流入,五日持仓占比变动分别为,1.04%,0.51%,0.44%,0.29%,0.27%。港股通数据为T+2数据,即今日披露数据为前两个交易日数据。","market":"us","thumbnail":"https://static.tigerbbs.com/1fc1f5e2fa377c378fa230c10e0849a2","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1fc1f5e2fa377c378fa230c10e0849a2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/data-rss/detail?id=2332","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_gelonghui","symbols":["90010","09926"],"gpt_icon":0}],"pageSize":4,"totalPage":28,"pageCount":1,"totalSize":112,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/90010\",params:#limit:6,delay:false,,,undefined,":[]}}